High Outlier
Strength
180 mg/1
Manufacturer
Bausch Health US LLCNDC
00187301330
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
9/17/2025
Active Ingredients
PYRIDOSTIGMINE BROMIDEApproval Type
New Drug (NDA)
FDA Application
NDA011665On Market Since
1/12/1959
Pharmacological Classes
Cholinesterase Inhibitor
Cholinesterase Inhibitors
Related Drugs
Same classification
ARICEPT 23 MG TABLET
Brand
62856024730•Eisai Inc.
$14.3864
per EA
ARICEPT 10 MG TABLET
Brand
62856024630•Eisai Inc.
$16.1969
per EA
ARICEPT 5 MG TABLET
Brand
62856024530•Eisai Inc.
$16.4368
per EA
NAMZARIC 21 MG-10 MG CAPSULE
Brand
00456122130•Allergan, Inc.
$19.7649
per EA
NAMZARIC 28 MG-10 MG CAPSULE
Brand
00456122830•Allergan, Inc.
$19.8156
per EA
NAMZARIC 7 MG-10 MG CAPSULE
Brand
00456120730•Allergan, Inc.
$19.8250
per EA
NAMZARIC 14 MG-10 MG CAPSULE
Brand
00456121430•Allergan, Inc.
$19.8307
per EA
EXELON 9.5 MG/24HR PATCH
Brand
00078050215•Novartis Pharmaceuticals Corporation
$21.5451
per EA
EXELON 9.5 MG/24HR PATCH
Brand
66758014331•Sandoz Inc.
$21.5451
per EA
EXELON 4.6 MG/24HR PATCH
Brand
00078050115•Novartis Pharmaceuticals Corporation
$21.9387
per EA